We are live on ! Find out more
WCMNY

Westchester Capital Management (New York) Portfolio holdings

AUM $2.21B
1-Year Est. Return 26.02%
This Fund
S&P 500
This Quarter Est. Return
+8.62%
1 Year Est. Return
+26.02%
3 Year Est. Return
+99.86%
5 Year Est. Return
+236.34%
10 Year Est. Return
+1,523.35%
AUM
$3.64B
AUM Growth
+$85.7M
Cap. Flow
-$35.8M
Cap. Flow %
-0.98%
Top 10 Hldgs %
32.26%
Holding
629
New
150
Increased
117
Reduced
17
Closed
182

Sector Composition

Rank Sector Weight
1 Financials 41.42%
2 Technology 12.77%
3 Healthcare 11.09%
4 Industrials 10.67%
5 Energy 4.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMAQW
426
DELISTED
International Media Acquisition Corp. Warrants
IMAQW
$1.2K ﹤0.01%
+50,000
New +$1.53K
FOXO.WS
427
DELISTED
FOXO Technologies Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
FOXO.WS
$1.18K ﹤0.01%
43,746
CFFS
428
DELISTED
CF Acquisition Corp. VII Class A Common Stock
CFFS
$1.03K ﹤0.01%
+101
New +$1.01K
CTAQW
429
DELISTED
Carney Technology Acquisition Corp. II Warrant
CTAQW
$1.01K ﹤0.01%
+16,767
New +$738
DLCAW
430
DELISTED
Deep Lake Capital Acquisition Corp. Warrant
DLCAW
$979 ﹤0.01%
279,857
CLAA.WS
431
DELISTED
Colonnade Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
CLAA.WS
$675 ﹤0.01%
29,998
+4,966
+20% +$385
EMBKW
432
DELISTED
Embark Technology, Inc. Warrants
EMBKW
$663 ﹤0.01%
33,331
FINMW
433
DELISTED
Marlin Technology Corporation Warrant
FINMW
$513 ﹤0.01%
320,401
PEPLW
434
DELISTED
PepperLime Health Acquisition Corporation Warrrant
PEPLW
$326 ﹤0.01%
+29,647
New +$925
NAACW
435
DELISTED
North Atlantic Acquisition Corporation Warrant
NAACW
$310 ﹤0.01%
30,086
EPHYW
436
DELISTED
Epiphany Technology Acquisition Corp. Warrant
EPHYW
$115 ﹤0.01%
+50,000
New +$1.39K
GSQD.WS
437
DELISTED
G Squared Ascend I Inc. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
GSQD.WS
$97 ﹤0.01%
97,248
AAC.U
438
DELISTED
Ares Acquisition Corporation Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
AAC.U
$93 ﹤0.01%
9
-339,019
-100% -$3.4M
PACXW
439
DELISTED
Pioneer Merger Corp. Warrant
PACXW
$90 ﹤0.01%
179,105
ESACU
440
DELISTED
ESGEN Acquisition Corporation Unit
ESACU
$42 ﹤0.01%
4
-174,996
-100% -$1.79M
CIIGU
441
DELISTED
CIIG Capital Partners II, Inc. Unit
CIIGU
$20 ﹤0.01%
2
-399,998
-100% -$4.01M
FLDDU
442
DELISTED
FTAC Emerald Acquisition Corp. Unit
FLDDU
$20 ﹤0.01%
2
-497,990
-100% -$4.95M
GRND icon
443
Grindr
GRND
$2.76B
-56,795
Closed -$590K
HYG icon
444
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
-760,000
Closed -$54.3M
MVST icon
445
Microvast
MVST
$354M
-200,000
Closed -$361K
OABI icon
446
OmniAb
OABI
$497M
-457,315
Closed -$4.67M
TLSI icon
447
TriSalus Life Sciences
TLSI
$352M
-414,265
Closed -$4.11M
VOD icon
448
Vodafone
VOD
$37.2B
-1,450,800
Closed -$16.4M
VOD icon
449
PUT
Vodafone
VOD
$37.2B
-9,000
Closed -$102K
WBD icon
450
Warner Bros
WBD
$69.3B
-17,465
Closed -$200K

Similar funds

Westchester Capital Management (New York)'s Q4 2022 Portfolio in Review

As of Q4 2022, Westchester Capital Management (New York) held 629 positions worth $3.64B, up 2.4% from $3.55B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Westchester Capital Management (New York)'s Q4 2022 filing shows 150 new, 117 increased, 17 reduced and 182 closed positions. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 1,253,044 shares worth $143M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $143M.

By sector, the portfolio is most concentrated in Financials at 41% of assets, up from 32% a quarter earlier, followed by Technology and Healthcare.

  • Westchester Capital Management (New York)'s largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 1,253,044 shares worth $143M.
  • Westchester Capital Management (New York) added most to Signify Health, Inc. in Q4 2022, an estimated $49.6M increase.
  • Westchester Capital Management (New York)'s biggest Q4 2022 reduction was Silicon Motion, cutting an estimated $61.4M.
  • Westchester Capital Management (New York) fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $143M.
  • Westchester Capital Management (New York)'s ten largest holdings make up 32% of its $3.64B portfolio in Q4 2022.
  • Westchester Capital Management (New York) opened 150 new positions and closed 182 in Q4 2022.
  • Westchester Capital Management (New York)'s portfolio value rose 2.4% quarter-over-quarter to $3.64B.

Based on Westchester Capital Management (New York)'s 13F filing for Q4 2022, filed 14 Feb 2023.